drugset / Trial / NCT06517914
A First-in-Human, Single- and Multiple-Ascending Dose Study of YH35995 in Healthy Adult Male Participants
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a randomized, double-blind, first-in-human study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple oral doses of YH35995
Timeline
- Start
- 2024-07-29
- Primary completion
- 2027-06
- Completion
- 2027-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | YH35995 | Unknown | — | Oral |
Indications
No indication recorded.